Published in AIDS Weekly, January 17th, 2000
"HIV infected HD patients have a very high morbidity and mortality," wrote Ahuja and colleagues from the University Medical Branch at Galveston, Texas. "Previous reports have suggested that the main predictor of survival of HIV infected HD patients is the stage of HIV infection (CD4 count). However, HAART has remarkably improved survival in HIV infected patients irrespective of the stage of HIV infection."
In order to evaluate if such an impact of HAART is seen in HIV infected HD patients, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.